The content of this article comes from the Internet, if it is inconsistent with the actual situation or there is infringement, please contact to delete. This article is only published in today's headlines, please do not move.
As we immerse ourselves in the serious threat of the pandemic, countries are actively taking measures to address this global challenge. Among them, the research and development of drugs has become a major hope for the treatment of new crown pneumonia. Recent news from Israel that one of their drugs, called EXO-CD24, performed well in phase II clinical trials and cured 90% of critically ill patients in just five days. This news offers a glimmer of hope, and here's where you'll learn more.
Israel has been showing rapid progress in epidemic prevention and control, especially in vaccination. Their new crown vaccination rate was once among the highest in the world, which is crucial for subsequent prevention and control efforts. Now, the "EXO-CD24" drug being developed by a team of Israeli experts has attracted widespread attention.
The drug was developed by a team led by Israeli expert Professor Alber, and phase I and phase II clinical trials have been remarkably successful. When treating 90 critically ill patients, 93% of them recovered and were discharged from the hospital in just five days. Encouragingly, this specific drug has little effect on the immune system and acts on the patient's lungs through nasal inhalation, providing a completely new approach to treatment.
It should be noted that variants of the new coronavirus have been detected in many countries around the world, and India experienced the second wave of the epidemic in April this year. This makes it more difficult for countries to prevent and control work, so Israel's drug research and development results are particularly important.
In addition to Israel, China is also actively involved in the research and development of new coronary pneumonia drugs. The new crown vaccine called "Kewesha" developed by Academician Chen Wei and CanSino's team has been approved, which can provide protection through a single injection. These efforts are all about defeating this global threat and giving us confidence in the future.
The above content and materials are derived from the Internet, and the author of this article does not intend to target or allude to any real country, political system, organization, race, individual. The above does not mean that the author of this article endorses the laws, rules, opinions, behaviors in the article and is responsible for the authenticity of the relevant information. The author of this article is not responsible for any issues arising above or related to any of the above, nor does it assume any direct or indirect legal liability.